Clinical trials
Observational Hemorrhage trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Hamilton Health Sciences Corporation | 2 |
| Hospital Álvaro Cunqueiro | 2 |
| Rigshospitalet, Denmark | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| ArtVentive Medical Group, Inc. | 1 |
| Azienda Ospedaliera Bolognini di Seriate Bergamo | 1 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 76 |
| Thrombosis | 11 |
| Stroke | 8 |
| Atrial Fibrillation | 7 |
| Hemostatic Disorders | 6 |
| Acute Coronary Syndrome | 5 |
| Myocardial Infarction | 4 |
| Coronary Artery Disease | 3 |
| Ischemic Stroke | 3 |
| Pulmonary Embolism | 3 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.